Orgenesis Inc. (ORGS)
OTCMKTS
· Delayed Price · Currency is USD
0.555
-0.045 (-7.50%)
Mar 5, 2026, 9:41 AM EST
Orgenesis Employees
Orgenesis had 146 employees as of December 31, 2023. The number of employees decreased by 21 or -12.57% compared to the previous year.
Employees
146
Change (1Y)
-21
Growth (1Y)
-12.57%
Revenue / Employee
$6,158
Profits / Employee
-$235,699
Market Cap
5.45M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Mosaic ImmunoEngineering | 8 |
| Synlogic | 1 |
| AccuStem Sciences | 2 |
| Bioxytran | 3 |
| Brainstorm Cell Therapeutics | 23 |
| NKGen Biotech | 26 |
Orgenesis News
- 1 year ago - Orgenesis Inc. Announces Acquisition of Certain Neurocords LLC Assets, Strengthening its Regenerative Medicine Portfolio with Spinal Cord Injury Therapies - Accesswire
- 1 year ago - Orgenesis Secures Up to $5 Million Equity Investment from Williamsburg Venture Holdings - Accesswire
- 1 year ago - Orgenesis Announces Positive Results From a Real-World Study of ORG-101 CAR-T Therapy in Patients with CD19+ Acute Lymphoblastic Leukemia - GlobeNewsWire
- 1 year ago - Orgenesis Announces Strategic Partnership with Harley Street Healthcare Group to Launch a State-of-the-Art Longevity & Wellness Initiative Globally - GlobeNewsWire
- 1 year ago - Orgenesis Provides Business Update for the First Quarter of 2024 - GlobeNewsWire
- 2 years ago - Orgenesis Provides Year End Business Update - GlobeNewsWire
- 2 years ago - Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility - GlobeNewsWire
- 2 years ago - Vered Caplan, CEO of Orgenesis, to Present at the Bioprocessing Summit Europe Conference - GlobeNewsWire